You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-rejection therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic GVHD Trial in Seattle (Immunosuppressive Therapy, Survey Administration)

Completed
Has Results
  • Chronic Graft Versus Host Disease
  • Immunosuppressive Therapy
  • Survey Administration
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 22, 2021

Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

Not yet recruiting
  • Multiple Myeloma
  • Allogeneic Stem Cell Transplantation
  • CARTemis-1
  • Santander, Cantabria, Spain
  • +4 more
Aug 1, 2023

Renal Transplant Rejection, Induction Therapy Trial (Rabbit Anti thymocyte globulin (rATG), Basiliximab)

Not yet recruiting
  • Renal Transplant Rejection
  • Induction Therapy
  • (no location specified)
Sep 22, 2022

Pre-transplant ICI Exposure and Post-transplant Graft Rejection

Recruiting
  • Graft Rejection
  • +3 more
  • Immune checkpoint inhibitor
  • Guangzhou, Guangdong, China
    Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
Jun 21, 2023

Antibody-mediated Rejection, Lung Transplant Rejection Trial (Extracorporeal Photopheresis)

Not yet recruiting
  • Antibody-mediated Rejection
  • Lung Transplant Rejection
  • Extracorporeal Photopheresis
  • (no location specified)
Oct 30, 2023

Study of Heart Transplant Rejection

Completed
  • Heart Transplantation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 7, 2023

    Donor-Derived Cell-Free DNA With Tocilizumab Treatment for

    Active, not recruiting
    • Rejection Chronic Renal
    • Kidney Transplant Rejection
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jul 18, 2022

      Antibody-mediated Rejection, Kidney Transplant; Complications, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

      Active, not recruiting
      • Antibody-mediated Rejection
      • +5 more
      • Los Angeles, California
        Norko Ammerman
      Mar 25, 2022

      ddcfDNA in Kidney Transplant Recipients

      Recruiting
      • Kidney Transplant Rejection
      • AlloSeq cfDNA
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Aug 22, 2023

      Pediatric Induction Therapy in Kidney Transplantation

      Completed
      • Kidney Transplant Rejection
      • Pediatric Kidney Disease
      • Basiliximab Injection
      • rabbit ATG
      • Guangzhou, Guangdong, China
      • +4 more
      Oct 15, 2023

      Kidney Injury, Kidney Failure, Kidney Failure, Chronic Trial in Washington (AlloSure, PAXGene)

      Suspended
      • Kidney Injury
      • +9 more
      • AlloSure
      • PAXGene
      • Washington, District of Columbia
        George Washington University
      Feb 16, 2023

      Heart Transplant Rejection Trial in Helsinki (Cell-free DNA)

      Recruiting
      • Heart Transplant Rejection
      • Cell-free DNA
      • Helsinki, Uusimaa, Finland
        Helsinki University Hospital
      Oct 2, 2023

      PD-1 /PD-L1 Inhibitor Therapy Before Liver Transplantation on

      Recruiting
      • Hepatocellular Carcinoma
      • Acute Rejection
        • Beijing, Beijing, China
          Beijing Tsinghua Changgung Hospital
        Jun 6, 2022

        Rejection Diagnosis in Kidney Transplants Patients

        Completed
        • Kidney Transplantation
        • +2 more
        • Kidney transplantation
        • Paris, France
          Hopital Saint-Louis
        Feb 9, 2022

        Kidney Transplantation, Kidney Transplant Rejection Trial in Los Angeles (Twice-daily Tacrolimus, Once-daily envarsus XR,

        Recruiting
        • Kidney Transplantation
        • Kidney Transplant Rejection
        • Twice-daily Tacrolimus
        • +5 more
        • Los Angeles, California
          University of Southern California
        Jun 6, 2022

        Antibody-mediated Rejection, Allosensitization Trial in New York (Isatuximab, bone marrow biopsy)

        Not yet recruiting
        • Antibody-mediated Rejection
        • Allosensitization
        • New York, New York
          NYU Langone Health
        May 16, 2023

        Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection Trial (Bone Marrow Mesenchymal Stem Cell Derived

        Not yet recruiting
        • Solid Organ Transplant Rejection
        • +2 more
        • Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment
        • (no location specified)
        Aug 16, 2022

        Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

        Not yet recruiting
        • Adenovirus
        • +2 more
        • Specific T- Lymphocytes
        • Pittsburgh, Pennsylvania
          UPMC Children's Hospital of Pittsburgh
        Sep 8, 2023

        Heart Transplantation Trial in Madrid (Autologous thyTreg)

        Recruiting
        • Heart Transplantation
        • Autologous thyTreg
        • Madrid, Spain
          Hospital General Universitario Gregorio Marañon
        Dec 5, 2022

        Kidney Failure, Chronic, End-Stage Renal Disease, Transplant Glomerulopathy Trial in Los Angeles (Clazakizumab)

        Active, not recruiting
        • Kidney Failure, Chronic
        • +6 more
        • Los Angeles, California
          Norko Ammerman
        Mar 25, 2022

        Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

        Not yet recruiting
        • Muscle-Invasive Bladder Carcinoma
        • +2 more
        • Guangzhou, Guangdong, China
          Cancer Center, Sun Yat-sen University
        Aug 3, 2023

        Therapy of Anti-NMDAR Encephalitis at Diagnosis

        Active, not recruiting
        • Anti-NMDA (N-Methyl D-Aspartate) Receptor Encephalitis
          • Rotterdam, Netherlands
            Erasmus Medical Center
          Sep 4, 2023

          Heart Transplant Rejection, Immune Suppression, Pediatric Heart Transplant Trial in Gainesville (DOT intervention)

          Not yet recruiting
          • Heart Transplant Rejection
          • +3 more
          • DOT intervention
          • Gainesville, Florida
            University of Florida
          Feb 8, 2023

          Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

          Recruiting
          • Acute Myeloid Leukemia Refractory
          • Acute Myeloid Leukemia, in Relapse
          • anti Tim-3/CD123 CAR-T cell therapy
          • Xuzhou, Jiangsu, China
            Kailin Xu
          Nov 4, 2023

          Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1 Trial in Shanghai (Camrelizumab (anti-PD-1 inhibitor), Apatinib

          Recruiting
          • Oral Squamous Cell Carcinoma
          • +3 more
          • Camrelizumab (anti-PD-1 inhibitor)
          • Apatinib (anti-VEGFR inhibitor)
          • Shanghai, Shanghai, China
            Ninth People's Hospital, Shanghai Jiao Tong University School of
          Oct 8, 2022